Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.

Professor of Respiratory Medicine and Allergy at the National Heart and Lung Institute, Imperial College London -- presented positive findings demonstrating the beneficial effects of Altesa ...

Novel anti-ST2 monoclonal antibody astegolimab modestly reduced chronic obstructive pulmonary disease (COPD) exacerbations in ...

Cytisinicline significantly increases quit rates in smokers with or without COPD while being safe and well tolerated.

The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...

In COPD, patient initiation and persistent use of guideline-concordant maintenance inhaled medications is subpar.

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...

Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...

An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...

Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a ...

Among patients with COPD, at least 50% reported that the disease impacts their daily life and emotional health, according to ...